Mark S. Nash, MD, Ph.D, FRCPC
Primary Investigator (Miami Site)
Dr. Nash has served on panels and research advisory boards for the NIH, CDC, and NIDILRR. He is currently an Editorial Board Member for Topics in SCI Rehabilitation, Chair of the ASIA Research & Awards Committee, and Chair of the PVA Consortium for Spinal Cord Medicine Guideline Panel on Cardiometabolic Disorders. Dr. Nash is PI for a DoD multi-center trial examining diabetes prevention after SCI through lifestyle intervention, and Co-PI on a DoD grant examining sleep disorders and cognitive dysfunction after SCI. Dr. Nash was PI for the NIDRR-funded multicenter trial examining Niaspan in Tetraplegia, for which he received the 2012 ASIA David Apple award. He is Co-Director of the NIDILRR South Florida SCI Model System, and PI for a recently awarded multi-center NIDILRR Disability Rehabilitation Research Project examining lifestyle intervention on cardiometabolic risks in stakeholders with SCI and their caregivers.
Dr. Nash has primary interests in assessment/treatment of cardiometabolic disease risks after SCI. He has published more than 100 peer-review articles, scholarly monographs, and book chapters on these themes and related topics within rehabilitation physiology.
Tenured Professor, Department of Neurological Surgery, Department of Physical Medicine & Rehabilitation, University of Miami Miller School of Medicine
Principal Investigator, Applied Physiology Research Laboratory, The Miami Project to Cure Paralysis (MP)
Director or Research, Department of Physical Medicine & Rehabilitation, University of Miami Miller School of Medicine